Covered recipient · General Payments record
RICHARD E HODGMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,551.22
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $466.70 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $171.53 | 14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.10 | 2 |
| Novo Nordisk AS | $57.75 | 3 |
| Amgen Inc. | $45.89 | 3 |
| Otsuka America Pharmaceutical, Inc. | $26.23 | 1 |
| GlaxoSmithKline, LLC. | $22.93 | 1 |
| Radius Health, Inc. | $20.21 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.46 | 1 |
| PFIZER INC. | $15.00 | 1 |
| Exact Sciences Corporation | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1.97 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926318 | CMS |
| ABBVIE INC. | $29.16 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926320 | CMS |
| ABBVIE INC. | $13.63 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926322 | CMS |
| ABBVIE INC. | $9.66 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926324 | CMS |
| ABBVIE INC. | $23.27 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926326 | CMS |
| ABBVIE INC. | $2.18 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926328 | CMS |
| ABBVIE INC. | $23.12 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926330 | CMS |
| ABBVIE INC. | $11.05 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926332 | CMS |
| ABBVIE INC. | $8.50 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926334 | CMS |
| ABBVIE INC. | $10.94 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926336 | CMS |
| ABBVIE INC. | $4.25 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926338 | CMS |
| ABBVIE INC. | $5.51 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926340 | CMS |
| ABBVIE INC. | $19.17 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926342 | CMS |
| ABBVIE INC. | $9.12 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103926344 | CMS |
| Amgen Inc. | $17.84 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117579998 | CMS |
| Amgen Inc. | $14.73 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117580000 | CMS |
| Amgen Inc. | $13.32 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117580002 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.72 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117943901 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $62.38 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117943903 | CMS |
| Exact Sciences Corporation | $13.60 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114704659 | CMS |
| GlaxoSmithKline, LLC. | $22.93 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115903065 | CMS |
| Novo Nordisk Inc | $13.60 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096887366 | CMS |
| Novo Nordisk Inc | $14.15 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096896563 | CMS |
| Novo Nordisk Inc | $30.00 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097532050 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.23 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118909217 | CMS |
| PFIZER INC. | $15.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131973815 | CMS |
| Radius Health, Inc. | $20.21 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089986767 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $17.46 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105917438 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.